Everyone seems to be talking about GLP-1 medications right now — but most of the conversation stops at Ozempic. If you've been researching semaglutide, tirzepatide, and retatrutide for fat loss, you've probably run into a wall of conflicting information, vague clinical language, and zero practical guidance on what to actually do. That gap between the prescription and the result is where most people lose their way.
Rob Polenik has spent years coaching 3,000+ clients through fat loss, contest prep, and peak body composition using a science-backed, individualized approach. With a Master's in Human Nutrition, an ACSM personal training certification, and a NASM Corrective Exercise Specialist credential, Rob doesn't just understand these drugs from a textbook perspective — he applies them in real-world coaching situations every single week. In this episode of the C3 Method Podcast, he breaks down exactly how semaglutide, tirzepatide, and retatrutide work, what makes each one distinct, and how to use them strategically for sustainable fat loss and body composition results.
By the time you finish reading, you'll know which peptide matches your specific situation, what the common mistakes look like, and the four practical tips that separate people who keep their results from those who rebound hard.
Before you can choose the right tool, you need to understand what's in each one. These three peptides represent a progression of development — each generation building on the last.
Semaglutide is the foundation. It's a GLP-1 agonist, meaning it mimics glucagon-like peptide-1, a hormone your body naturally produces after eating to signal fullness. The problem with your body's naturally produced GLP-1 is that it has a lifespan of only a few minutes. Semaglutide extends that signal dramatically, giving you a sustained feeling of fullness. The practical effect: your appetite is suppressed and staying in a caloric deficit feels significantly more manageable.
As people pushed semaglutide to higher doses to manage more intense hunger, nausea became a real problem. That side effect drove the development of tirzepatide, which layers in a second receptor agonist called GIP — glucose-dependent insulinotropic polypeptide. GIP helps reduce the nausea associated with aggressive GLP-1 dosing, and it also improves insulin sensitivity and helps lower A1C. This is why tirzepatide has largely become the new standard recommendation at most wellness clinics. You get more control with fewer gut-related complaints.
Retatrutide (also sometimes pronounced "retatrutide" — Rob uses both interchangeably) adds a third mechanism: glucagon. That triple combination — GLP-1, GIP, and glucagon — is where things get particularly interesting for body composition goals. The glucagon component specifically targets visceral fat, the stubborn fat stored around your organs and in your midsection. It does this by making the process of storing carbohydrates into muscle cells metabolically inefficient, which forces your body to burn more fat as energy during that process. At the time of recording, retatrutide has not yet received FDA approval but is available through wellness clinics.
Choosing between these three isn't just about which one is the most advanced — it's about matching the tool to your actual needs and budget.
If your hunger is only really a problem when you push into a significant caloric deficit — but at maintenance or a small deficit you're doing just fine — semaglutide is likely all you need. It's the most focused appetite suppressant of the three because 100% of its mechanism is GLP-1. It's also the cheapest option. If you don't need the added benefits of nausea control or visceral fat targeting, there's no reason to pay more.
If you struggle with hunger at maintenance calories — or the moment you enter any kind of deficit you feel like you're white-knuckling it — tirzepatide is the smarter starting point. The GIP component means you can push the appetite suppressant effect harder without hitting the nausea wall that semaglutide can create at higher doses. The added insulin sensitivity benefits are also worth considering if you're using other compounds that can interfere with insulin function.
Retatrutide is for people who want everything — appetite suppression, nausea management, insulin support, and targeted visceral fat reduction. It's the most powerful and the most expensive. Here's the important nuance though: because the appetite suppressant (GLP-1) is now only one-third of what's in the drug, the per-dose hunger-blunting effect is actually lower than semaglutide. You may need to take a higher volume to get the same appetite suppression, which drives costs even higher. Go into retatrutide knowing you're paying for the full-spectrum effect, not just a more powerful appetite suppressor.
Understanding which drug to use is only half the equation. How you use it determines whether your results stick or vanish within two months of stopping.
The standard recommendation of once weekly exists mostly for patient compliance — not because it's the optimal protocol. In practice, many people experience the strongest effects in the first 12 to 24 hours after injection, then notice hunger creeping back around days three to five. This creates a pattern where you're disciplined Monday through Wednesday, then you're raiding the pantry Thursday through Sunday.
Splitting your dose into two smaller injections per week smooths out those peaks and valleys. It also means you don't need as large a dose per injection — because you're only trying to cover three days at a time, not seven. That smaller-per-injection amount also directly reduces nausea. Less drug at once, more even coverage throughout the week.
When you're in a caloric deficit, your two biggest risks are muscle loss and digestive sluggishness. High protein — aim for at least 0.8 to 1 gram per pound of bodyweight — helps preserve lean muscle that would otherwise be cannibalized during a deficit. And because you're eating less overall, glycogen stores in your muscles drop, which means your muscles hold less water. Intentionally increasing your daily water intake keeps muscle tissue hydrated, reduces stiffness and soreness, supports recovery from your training, and keeps digestion moving. Both of these things compound each other — and both take deliberate effort when your appetite is suppressed.
The goal is not to eliminate hunger. The goal is to make hunger manageable. This distinction matters more than most people realize, for two reasons. First, staying sensitive to hunger means you remain sensitive to your body's other signals — digestion quality, muscle soreness, energy levels. That feedback loop helps you fine-tune your nutrition in real time. Second, and more importantly, if you completely switch off hunger, you never learn how to manage it. The peptide becomes a crutch rather than a bridge.
Think of it this way: if hunger on a scale of one to ten hits a nine or ten, you're going to break. But if you get it down to a three or four, you can learn to sit with that, make smart food choices around it, and actually build the skill of hunger management. That skill is what keeps the weight off after you taper off the drug.
This is probably the most ignored piece of advice in the entire GLP-1 conversation, and it's the one that causes the worst rebounds. Think of your dosing schedule as a bell curve: you ramp up carefully to find your effective dose, you maintain that through your fat loss phase, and then as you approach your goal you start ramping back down intentionally.
If you stop abruptly, your body is still in a major caloric deficit but the appetite suppression is suddenly gone. The result is overwhelming hunger — your body's emergency signal to restore the energy it's been short on. People who quit cold turkey often undo months of work in just four to eight weeks.
Tapering gives your body time to adjust, gives you the opportunity to practice hunger management with gradually less pharmaceutical support, and brings your caloric intake back toward maintenance in a controlled way. It's the difference between a soft landing and a crash.
Ready to Put This Into Practice?
Every body is different. Rob works one-on-one with clients to build personalized nutrition and training plans that actually stick. With 3,000+ clients coached and results ranging from Pro Cards to D1 scholarships, the C3 Method delivers.
Book Your Free Consultation — limited spots available.
One context where these drugs become particularly powerful — and where the stakes of misuse are highest — is competitive physique sports. Rob discusses a current client who came to him with a complicated relationship with food rooted in emotional eating, stress-based eating, and a difficult childhood in which food was an escape. That client started competing in part as a structural motivation tool for controlling their nutrition.
But what happens when the show is over and the external pressure of a competition deadline disappears? That's the real challenge. The peptides, used correctly, become a bridge through that psychologically vulnerable post-show window. A 20 to 24-week contest prep followed by a cold-turkey drug discontinuation and no behavioral framework is a recipe for a catastrophic rebound — not because the person lacks willpower, but because the physiological and psychological pressures both peak simultaneously.
Using semaglutide, tirzepatide, or retatrutide in a post-show recovery phase helps blunt that aggressive hunger rebound while the competitor re-establishes a sustainable maintenance routine. The key is that it works best when combined with the psychological work of understanding why you eat — not just suppressing the signal entirely.
Q: Is tirzepatide stronger than semaglutide for fat loss?
Tirzepatide produces greater average fat loss in clinical trials largely because it allows for better dose escalation without the nausea ceiling that limits semaglutide. That said, semaglutide delivers more concentrated appetite suppression per unit of active compound since the entire mechanism is GLP-1. "Stronger" depends on your goal and your tolerance profile.
Q: Can retatrutide really target belly fat specifically?
The glucagon component in retatrutide does have a preferential effect on visceral adipose tissue — the fat stored around your organs and in your midsection. The mechanism involves making carbohydrate storage in muscle cells metabolically inefficient, which forces more fat to be used as fuel. It's not magic spot reduction, but it does appear to meaningfully accelerate visceral fat loss compared to GLP-1 alone.
Q: What happens when you stop taking semaglutide or tirzepatide?
If you stop abruptly, most people experience a significant rebound in appetite as the drug clears your system while your body is still in an energy-deficient state. This is why tapering is critical. Hunger surges back hard, and without the behavioral skills or a gradual reduction in drug support, it's very easy to overeat aggressively in the weeks that follow. A planned taper, paired with a shift toward maintenance calories, dramatically reduces this risk.
Q: How do you know what dose to take?
The minimum effective dose is always the starting point — enough to make hunger manageable without eliminating it entirely. Dose escalation should be gradual and driven by your actual hunger response, not by a standard protocol. Splitting doses into twice-weekly injections often allows you to achieve the same effect with a lower total weekly amount, which reduces both cost and side effects.
Q: Should you still lift weights while on these peptides?
Absolutely — and this isn't optional if your goal is body composition rather than just weight loss. Because you're eating in a significant caloric deficit, your body will break down muscle for energy if given the opportunity. Resistance training is the primary signal that tells your body to preserve that muscle tissue. Combined with high protein intake, lifting is what separates a fat loss result from a "skinny fat" result.
Q: Can these peptides help with emotional or stress-based eating?
They can support the process, but they're not a replacement for addressing the underlying behavior. What they do well is reduce the physiological urgency of hunger so that emotional eating triggers become easier to recognize and pause before acting on. The peptide lowers the noise enough for you to hear the actual psychological signal — but the behavioral work of learning to respond differently to that signal still has to happen deliberately.
Semaglutide, tirzepatide, and retatrutide are genuinely powerful tools for fat loss and body composition — but like any tool, how you use them determines whether you get results that last or results that evaporate the moment you stop. Understanding the mechanism behind each one helps you choose intelligently. Applying the four practical protocols — splitting doses, prioritizing protein and hydration, using the minimum effective dose, and tapering off gradually — helps you actually keep what you earn.
The people who struggle with these drugs aren't failing because the drugs don't work. They're failing because nobody gave them a framework for using them as a bridge to sustainable habits rather than a shortcut that sidesteps them. That's the C3 Method difference: the drug is the support structure, and the skills you build while using it are what you carry forward for life.
Take the Next Step
If today's episode resonated with you, imagine having this level of guidance personalized to your exact goals, schedule, and body. That's what working with Rob looks like.
Want to hear Rob walk through all of this in his own words — including the real client story behind this episode and the nuanced conversation around psychological relationships with food and competitive dieting? Give the full episode a listen.